Two Clinical Trials Assessing Treatments for Eosinophilic Esophagitis. Reply.

Chehade, Mirna; Dellon, Evan S; Spergel, Jonathan M

Chehade, Mirna; Dellon, Evan S; Spergel, Jonathan M.

Affiliation

Chehade M; Icahn School of Medicine at Mount Sinai, New York, NY mirna.chehade@mssm.edu.
Dellon ES; University of North Carolina School of Medicine, Chapel Hill, NC.
Spergel JM; Children's Hospital of Philadelphia, Philadelphia, PA.

N Engl J Med ; 391(11): 1066-1067, 2024 Sep 19.

Article in En | MEDLINE | ID: mdl-39292938

Subject(s)

Antibodies, Monoclonal, Humanized; Eosinophilic Esophagitis; Humans; Eosinophilic Esophagitis/diagnosis; Eosinophilic Esophagitis/drug therapy; Eosinophilic Esophagitis/immunology; Eosinophilic Esophagitis/pathology; Treatment Outcome; Randomized Controlled Trials as Topic; Immune Tolerance/drug effects; Antibodies, Monoclonal, Humanized/administration & dosage; Antibodies, Monoclonal, Humanized/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Eosinophilic Esophagitis / Antibodies, Monoclonal, Humanized Limits: Humans Language: En Journal: N Engl J Med Year: 2024 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google